Innovating Works
HORIZON-CL4-2024-RESILIEN...
HORIZON-CL4-2024-RESILIENCE-01-36: Advanced biomaterials for the Health Care (IA)
Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Several materials specifications and related innovations needs will support this topic such as renewable and recyclable materials, alternative active ingredients, design for circularity, lightweight materials. The topic should address several key policies of the European Union such as Circular Economy Action Plan, EU Chemicals strategy.
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 07-02-2024.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Hace más de 14 mes(es) del cierre y aún no tenemos información sobre los proyectos financiados, no parece que se vaya a publicar esta información.
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos:

Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Several materials specifications and related innovations needs will support this topic such as renewable and recyclable materials, alternative active ingredients, design for circularity, lightweight materials. The topic should address several key policies of the European Union such as Circular Economy Action Plan, EU Chemicals strategy.

Projects are expected to contribute to the following outcomes:

Develop the swiftly growing innovation market of medical applications, which is dependent on advanced biocompatible materials that can be printed or injected, including 4D materials that change their 3D structures following external impact (e.g. thermic, electric, mechanical or radiation treatment).Medical and/or surgical procedures will benefit from injectable materials for non-invasive surgical procedures.Some of their advantages include easy deliverability into the body, increased implantation precision, controllable release of therapeutic agents, antimicrobial properties and the possibility of monitoring or stimulating biologi... ver más

Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Several materials specifications and related innovations needs will support this topic such as renewable and recyclable materials, alternative active ingredients, design for circularity, lightweight materials. The topic should address several key policies of the European Union such as Circular Economy Action Plan, EU Chemicals strategy.

Projects are expected to contribute to the following outcomes:

Develop the swiftly growing innovation market of medical applications, which is dependent on advanced biocompatible materials that can be printed or injected, including 4D materials that change their 3D structures following external impact (e.g. thermic, electric, mechanical or radiation treatment).Medical and/or surgical procedures will benefit from injectable materials for non-invasive surgical procedures.Some of their advantages include easy deliverability into the body, increased implantation precision, controllable release of therapeutic agents, antimicrobial properties and the possibility of monitoring or stimulating biological events. Medical suppliers can commercialise injectable hydrogels, including those made of nanocomposite, natural and synthetic polymer-based biomaterials, bone cements, bio-ceramics and electronics.

Scope:Proposals should address at least four of the following activities:

To enable a fast development of new advanced novel injectable biomaterials, digital tools such as modelling, simulation and characterisation techniques (including those provided by analytical infrastructures) assisted by advanced methods e.g. physics-based methods, machine learning or artificial intelligence.The innovation market of medical applications is fast growing and dependent on advanced biocompatible materials that can be printed or injected. The 4D materials will change their 3D structures after external impact such as thermic, electric, mechanical or radiation treatment.Proposals shall demonstrate new engineering strategies that present functional characteristics beyond bio-compatibility, and express properties that can be used to control the physiological environment (shape-memory, self-healing properties) and induce a response.Proposals shall address biomaterials with antibacterial properties contributing to the widespread bottleneck of antimicrobial resistance often encountered in clinical careDemonstrate the scaling of injectable hydrogels, including those made of nanocomposite, natural and synthetic polymer-based biomaterials, bone cements, bio-ceramics and electronics.The design for circularity has to develop, when relevant, bio-degradable or bio-absorbable biomaterials that are gradually eliminated by the body after fulfilling a purpose. The biomaterials used should be safe and sustainable by design (SSbD), taking also into account any specific medical requirements.

Proposals submitted under this topic should include a business case and exploitation strategy, as outlined in the introduction to this Destination.

This topic requires the effective contribution of SSH disciplines and the involvement of SSH experts, institutions as well as the inclusion of relevant SSH expertise, in order to produce meaningful and significant effects enhancing the societal impact of the related research activities. An early involvement of end users could be essential.

Projects should build on or seek collaboration with existing projects and develop synergies with other relevant European, national or regional initiatives, funding programmes and platforms.#

Where relevant, proposals should seek links with and capitalise on the results of past and ongoing EU funded research projects, including the ones under Cluster 1 “Health” and Cluster 6 'Food, Bioeconomy, Natural Resources, Agriculture and Environment.

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Several materials specifications and related innovations needs will support this topic such as renewable and recyclable materials, alternative active ingredients, design for circularity, lightweight materials. The topic should address several key policies of the European Union such as Circular Economy Action Plan, EU Chemicals strategy. Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Several materials specifications and related innovations needs will support this topic such as renewable and recyclable materials, alternative active ingredients, design for circularity, lightweight materials. The topic should address several key policies of the European Union such as Circular Economy Action Plan, EU Chemicals strategy.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Subcontracting costs.
Purchase costs.
Other cost categories.
Indirect costs.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 6:. Se cuenta con prototipos piloto capaces de desarrollar todas las funciones necesarias dentro de un sistema determinado, habiendo superado pruebas de factibilidad en condiciones de operación o funcionamiento real. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Para el presupuesto subvencionable la intensidad de la ayuda en formato fondo perdido podrá alcanzar desde un 70% hasta un 100%.
The funding rate for IA projects is 70 % for profit-making legal entities and 100 % for non-profit legal entities. The funding rate for IA projects is 70 % for profit-making legal entities and 100 % for non-profit legal entities.
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda no tiene efecto incentivador. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea pero en los últimos 6 meses la línea ha concecido
Total concedido en los últimos 6 meses.
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
HORIZON-CL4-2024-RESILIENCE-01-TWO-STAGE Advanced biomaterials for the Health Care (IA) Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Severa...
Sin info.
HORIZON-CL4-2024-RESILIENCE-01-36 Advanced biomaterials for the Health Care (IA)
en consorcio: Expected Outcome:This topic refers to the innovation market for Healthcare and Medicine, which affects many citizens and their needs. Severa...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de
HORIZON-CL4-2024-RESILIENCE-01-35 Biodegradable polymers for sustainable packaging materials (IA)
en consorcio: Expected Outcome:Projects are expected to contribute to the following outcomes: The packaging industry will have access to the next generat...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de
HORIZON-CL4-2024-RESILIENCE-01-04 Technologies for processing and refining of critical raw materials (IA)
en consorcio: ExpectedOutcome:Projects outcomes will enable achieving the expected impacts of the destination by increasing access to primary raw material...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de
HORIZON-CL4-2024-RESILIENCE-01-01 Exploration of critical raw materials in deep land deposits (RIA)
en consorcio: ExpectedOutcome:Projects outcomes will enable achieving the expected impacts of the destination by increasing access to primary raw material...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de
HORIZON-CL4-2024-RESILIENCE-01-10 Addressing due diligence requirements in raw materials supply chains. (CSA)
en consorcio: ExpectedOutcome:Projects outcomes will enable achieving the expected impacts of the destination by increasing access to primary raw material...
Cerrada hace 1 año | Próxima convocatoria prevista para el mes de